Polymorphism and stability of ibuprofen/nicotinamide cocrystal: The effect of the crystalline synthesis method

被引:30
作者
Guerain, M. [1 ]
Guinet, Y. [1 ]
Correia, N. T. [1 ]
Paccou, L. [1 ]
Danede, F. [1 ]
Hedoux, A. [1 ]
机构
[1] Univ Lille, UMET Unite Mat & Transformat, CNRS, INRAE,Cent Lille,UMR 8207, F-59000 Lille, France
关键词
PHARMACEUTICAL COCRYSTALS; RACEMIC IBUPROFEN; CO-CRYSTALS; RAMAN; NICOTINAMIDE; SPECTROSCOPY; SOLUBILITY; CAFFEINE;
D O I
10.1016/j.ijpharm.2020.119454
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The development over the past decade of design strategies for cocrystal preparation have led to numerous methods for the synthesis of cocrystal without take care of their influence on the precise structure and stability of cocrystalline states. On the other hand the mechanism of cocrystal formation remains widely unclear, especially the identification of the type of interactions mostly responsible for the cocrystalline stability. The present study focuses on the influence of the crystalline synthesis method on the polymorphism of cocrystals was analyzed from the preparation of S-ibuprofen/nicotinamide and RS-ibuprofen/nicotinamide cocrystals by co-milling, slow solvent evaporation and crystallization from the melt. X-ray diffraction and Raman spectroscopy experiments have shown that the polymorphic form of the cocrystals obtained by recrystallization from the melt (Form A) is different from that prepared by milling and by slow evaporation in solution (Form B). It was shown that both isothermal and non-isothermal recrystallizations from the melt blending are observed via a transient metastable micro/nano structure of form A. Additionally, it was observed that form A transforms into Form B upon heating via very weak changes in the hydrogen bond network. The crystallization in form A from the melt, instead of form B by other methods, was explained by the difficulty to form a supramolecular organization too far energetically from that existing in the melt. This study shows the crucial role of supramolecular H-bonding on the formation mechanism of cocrystals and how does the synthesis method of cocrystals change the supramolecular organization and the related structure of cocrystals. © 2020 Elsevier B.V.
引用
收藏
页数:10
相关论文
共 40 条
  • [1] Synthesis and Supramolecularity of Hydrogen-Bonded Cocrystals of Pharmaceutical Model Rac-Ibuprofen with Pyridine Derivatives
    Alshahateet, Solhe F.
    [J]. MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2010, 533 : 152 - 161
  • [2] [Anonymous], 2007, MODEL LISTS ESSENTIA
  • [3] Applying hot-stage microscopy to co-crystal screening: A study of nicotinamide with seven active pharmaceutical ingredients
    Berry, David J.
    Seaton, Colin C.
    Clegg, William
    Harrington, Ross W.
    Coles, Simon J.
    Horton, Peter N.
    Hursthouse, Michael B.
    Storey, Richard
    Jones, William
    Friscic, Tomislav
    Blagden, Nicholas
    [J]. CRYSTAL GROWTH & DESIGN, 2008, 8 (05) : 1697 - 1712
  • [4] Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
    Blagden, N.
    de Matas, M.
    Gavan, P. T.
    York, P.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 617 - 630
  • [5] Brittain H.G., 2019, BRITTAIN EXCIPIENTS, P415, DOI [10.1016/bs.podrm.2018.11.004, DOI 10.1016/BS.PODRM.2018.11.004]
  • [6] Pharmaceutical cocrystals: The coming wave of new drug substances
    Brittain, Harry G.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (02) : 311 - 317
  • [7] PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS
    BYRN, S
    PFEIFFER, R
    GANEY, M
    HOIBERG, C
    POOCHIKIAN, G
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (07) : 945 - 954
  • [8] Cocrystals: Solution, Mechanochemistry, and Sublimation
    Carstens, Thalia
    Haynes, Delia A.
    Smith, Vincent J.
    [J]. CRYSTAL GROWTH & DESIGN, 2020, 20 (02) : 1139 - 1149
  • [9] Simultaneously Improving the Mechanical Properties, Dissolution Performance, and Hygroscopicity of Ibuprofen and Flurbiprofen by Cocrystallization with Nicotinamide
    Chow, Shing Fung
    Chen, Miles
    Shi, Limin
    Chow, Albert H. L.
    Sun, Changquan Calvin
    [J]. PHARMACEUTICAL RESEARCH, 2012, 29 (07) : 1854 - 1865
  • [10] Davey R.J., 2002, POLYMORPHISM MOL CRY, P675, DOI [10.1021/cg020039a, DOI 10.1021/CG020039A]